Western New England University professor Dr. Seth Housman was recently named one of the 2020 Stand Up To Superbugs Ambassadors by The Pew Charitable Trust Network. More than 40 individuals from across the country gathered in Washington in late February as part of The Pew Charitable Trusts' Stand Up To Superbugs initiative.
Stand Up to Superbugs is a diverse group of people from across the U.S. who are working to combat antibiotic-resistant bacteria and prevent a return to the pre-antibiotic era when simple infections accounted for at least one-third of all deaths. They do this by supporting three things: innovation to reinvigorate the pipeline of antibiotics in development, the responsible use of existing antibiotics in veterinary and human medicine, and increased federal funding.
Stand Up To Superbugs Ambassadors are part of The Pew Charitable Trusts' network of survivors, farmers, doctors, researchers, and others with a personal connection to the issue of antibiotic resistance. They are sharing their unique experiences and perspectives to help raise awareness about the growing public health and national security threat posed by drug-resistant bacteria. Of the more than 40 ambassadors from across the country, Dr. Housman is one of only five pharmacists on the team.
Seth Housman, Pharm.D., M.P.A., is a clinical assistant professor of acute care in the department of pharmacy practice at Western New England University. He maintains a practice site at Baystate Medical Center as an infectious diseases pharmacy specialist and assistant residency program director for the second-year postgraduate infectious diseases pharmacy residency. His research interests include optimizing antimicrobial dosing to overcome antimicrobial resistance.
The College of Pharmacy and Health Sciences educates the leaders of tomorrow in the health and wellness fields through innovative doctoral programs. For more information about programs visit Western New England University's College of Pharmacy and Health Sciences.
Dr. Housman was recently interviewed regarding potential coronavirus treatments.
